Discover delivery innovation with powerful partnership potential

This year’s agenda will cover the key areas that raise challenges in drug delivery and are experiencing consistent change and innovation.

You’ll hear┬áthe latest success stories, case studies and breakthroughs within biologics and small molecules. Including:

  • Improving bioavailability, solubility and stability
  • Continuous process optimisation
  • Novel targeted delivery technologies
  • Vaccine development
  • Oral delivery
  • Transdermal delivery technology
  • Solutions for improved permeability
  • Gene therapy approaches
  • Paediatric formulation and delivery methods

 

Check out the 2016 agenda here.

 …

Confirmed Speakers Include…

  • Arvind Srivastava, Director of Formulation Development, Eli Lilly
  • Avinash Nangia, VP, R&D, Lupin Pharmaceuticals
  • John Higgins, Director of Basic Pharmaceutical Sciences & Senior Principal Scientist, Merck & Co.
  • Sotirios Koutsopoulos, Research Scientist, Center for Biomedical Engineering, MIT

New for 2016

  • 4 more hours of thought-leadership
  • 8 new sessions devoted to technology innovation
  • 6 hours of iSolve clinics dedicated to meeting your key industry challenges
  • BIOLOGICS
    Assessing the Latest in Topical and Transdermal Delivery Platforms: Exploring...
  • THOUGHT LEADERSHIP
    Future Development of Novel Excipients to Improve Drug Formulation and...
  • SMALL MOLECULES
    Modeling and Simulation: Improving Development Timelines by Designing...
  • INNOVATION SPOTLIGHT
    Developing a Strategy for Continuous Manufacturing at Pfizer: Advancing...

Twitter

Check out the video from the European Summit